GW Pharmaceuticals PLC Holding(s) in Company (8986N)
October 31 2016 - 11:29AM
UK Regulatory
TIDMGWP
RNS Number : 8986N
GW Pharmaceuticals PLC
31 October 2016
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------------------------------------
1. Identity of the issuer or GW PHARMACEUTICALS PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------ ------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
--------------------------------------------------------------------------------
An acquisition or disposal of voting rights ü
------------------------------------------------------- -----------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------- -----------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------- -----------------------
An event changing the breakdown of voting rights
------------------------------------------------------- -----------------------
Other (please
specify):
----------------------------------------------------- -----------------------
3. Full name of person(s) FMR LLC
subject to the
notification obligation:
(iii)
------------------------------------------------------ ------------------------
4. Full name of shareholder(s) See Section 9
(if different from 3.):(iv)
------------------------------------------------------ ------------------------
5. Date of the transaction 27 October 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------ ------------------------
6. Date on which issuer 31 October 2016
notified:
------------------------------------------------------ ------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 5%
------------------------------------------------------ ------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- ---------------- ---------------- -------------- ----------------------- -------------------------
Indirect Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------ ------------ -------------- --------- ------------ ------------ -----------
GB0030544687 13,665,180 13,665,180 15,807,180 15,807,180 5.23%
---------------- ---------------- -------------- --------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ -------------- -------------------------------- ------------------------- ---------------------
Right of Recall 5,497,200 1.82%
------------------ -------------- -------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
---------------- -------------- -------------- ---------------- ------------------------- -----------------------
Nominal Delta
---------------- -------------- -------------- ---------------- ------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------- ----------------------------------------------------------------
21,304,380 7.05%
---------------------------------------------------- ----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------------------------------
Percentage
Controlled Undertaking Holding
----------------------------------------- -----------
Fidelity Institutional Asset Management
Trust Company 0.03
----------------------------------------- -----------
FMR CO., INC 7.02
----------------------------------------- -----------
Grand Total 7.05
----------------------------------------- -----------
Proxy Voting:
--------------------------------------------------------------------------------------------
10. Name of the proxy holder:
-------------------------------------------------------------- ----------------------------
11. Number of voting rights proxy
holder will acquire:
-------------------------------------------------------------- ----------------------------
12. Date on which proxy holder will
acquire voting rights:
-------------------------------------------------------------- ----------------------------
13. Additional information:
------------------------------------------------------------ ------------------------------
14. Contact name: Sally-Ann Hatton
------------------------------------------------------------ ------------------------------
15. Contact telephone number:
fil-regreporting@fil.com,
01737 837148
------------------------------------------------------------ ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEASEFDAPKFFF
(END) Dow Jones Newswires
October 31, 2016 11:29 ET (15:29 GMT)
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Dec 2023 to Dec 2024
